Back
Ascletis Pharma, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
62
ASCLF
Ascletis Pharma, Inc.
Last Price:
$1.7100
Seasonality Move:
292.64%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAscletis Pharma, Inc. Stock Forecast
-
Is Ascletis Pharma, Inc. Stock Undervalued?The current Ascletis Pharma, Inc. [ASCLF] share price is $1.7100. The Score for ASCLF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ASCLF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Ascletis Pharma, Inc. Stock Go Up Next Year?
Data Unavailable
Ascletis Pharma, Inc. Stock Rating
Data Unavailable
Ascletis Pharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
China
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascletis.com
52-Week Data
52-Week High:
2.2900
52-Week Low:
0.2393
Prediction Charts
Market Cap:
1.7B
Price in USD:
1.7100
Volume:
0
Beta:
-12.5911
Technical Analysis
SMA50:
1.5088
SMA100:
1.5357
SMA200:
1.2619
52-Wk Change:
614.58%
Stock Predictions
-
Is Ascletis Pharma, Inc. stock public?Yes, Ascletis Pharma, Inc. is a publicly traded company.
-
What is the Ascletis Pharma, Inc. stock quote today?The Ascletis Pharma, Inc. stock price is 1.7100 USD today.
-
How to buy Ascletis Pharma, Inc. stock online?You can buy Ascletis Pharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 1.7800 | 1.7800 | 1.7800 | 1.7800 |
| Dec-3 | 1.4500 | 1.4500 | 1.4500 | 1.4500 |
| Dec-4 | 1.5800 | 1.5800 | 1.5800 | 1.5800 |
| Dec-5 | 1.7400 | 1.7400 | 1.7400 | 1.7400 |
| Dec-8 | 1.9000 | 1.9000 | 1.9000 | 1.9000 |
| Dec-9 | 2.2400 | 2.1265 | 2.2900 | 2.1265 |
| Dec-10 | 2.1400 | 2.0300 | 2.1400 | 2.0000 |
| Dec-11 | 2.0300 | 2.0300 | 2.0300 | 2.0300 |
| Dec-12 | 2.0300 | 2.0300 | 2.0300 | 2.0300 |
| Dec-15 | 2.0300 | 2.0300 | 2.0300 | 2.0300 |
| Dec-16 | 2.0300 | 2.0300 | 2.0300 | 2.0300 |
| Dec-17 | 2.0300 | 2.0300 | 2.0300 | 2.0300 |
| Dec-18 | 1.7100 | 1.7100 | 1.7100 | 1.7100 |
| Dec-19 | 1.7100 | 1.7100 | 1.7100 | 1.7100 |
Ascletis Pharma, Inc. Earnings
Data Unavailable
Ascletis Pharma, Inc. Forecast Revenue Growth
Data Unavailable
* Ascletis Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.